Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver
Wenshu Tang(Chinese University of Hong Kong), Alfred S.L. Cheng(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong), John Wong(Chinese University of Hong Kong), Jingying Zhou(Ningbo University Affiliated Hospital), Howard H.W. Leung(Chinese University of Hong Kong), Heung Man Lee(Chinese University of Hong Kong), Yong Hou(Chinese Academy of Medical Sciences & Peking Union Medical College), Joseph J.�Y. Sung(Nanyang Technological University), Zhixian Liang(Chinese University of Hong Kong), Ka‐Fai To(Chinese University of Hong Kong), Xuezhen Zeng(Sun Yat-sen University), Myth T.S. Mok(Chinese University of Hong Kong), Alice P.S. Kong(Chinese University of Hong Kong), Kelvin K. Ng(Chinese University of Hong Kong), Philip Chun Yeung(Chinese University of Hong Kong), Zhewen Xiong(Chinese University of Hong Kong), Lingyun Zhang(Chinese University of Hong Kong), Jing Wang(Naval Medical Research Command), Xiaoyu Liu(Shanghai Ninth People's Hospital), Yu Feng(Central South University of Forestry and Technology), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Weiqin Yang(Chinese University of Hong Kong), Anthony W.H. Chan(Chinese University of Hong Kong), Jiahuan Lu(Sun Yat-sen University), Hanyong Sun(Shanghai Jiao Tong University), Simon K.H. Wong(Chinese University of Hong Kong), Haoran Wu(Beijing University of Chinese Medicine), Candice C. Lam(Chinese University of Hong Kong), Jingqing Li(Sun Yat-sen University)
Cited by 112
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k